PPT-EGFR Mutation in Lung Adenocarcinoma (ADC)
Author : QuietConfidence | Published Date : 2022-08-04
Ana Rima Lung Cancer Incidence and Mortality New cases in 2013 228190 40 with stage IV disease at presentation 90000 160000 deaths in 2012 comparable to prostate
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "EGFR Mutation in Lung Adenocarcinoma (A..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
EGFR Mutation in Lung Adenocarcinoma (ADC): Transcript
Ana Rima Lung Cancer Incidence and Mortality New cases in 2013 228190 40 with stage IV disease at presentation 90000 160000 deaths in 2012 comparable to prostate pancreas breast and colon cancer combined. Ben Lester, Mike Steele, Quinn Morrison. Topics. Introduction. Why?. Types and Comparisons. Successive Approximation ADC example. Applications. ADC System in the CML-12C32 Microcontroller. Analog systems are typically what engineers need to analyze. ADCs are used to turn analog information into digital data.. John Milne PhD, NIBRT. 20. th. . June 2014. Ehrlich reasoned that if a compound could be made . that. selectively . targeted a disease-causing organism, . then . a toxin . for. . . that organism could be delivered along . TKI. s. . and . related. . treatment . strategies. Rafal . Dziadziuszko. Medical. . University. of Gdańsk, Poland. 16th European . Congress. „. Perspectives. in . Lung. Cancer. ” . Torino. Increases . Safety Window in Preclinical Studies. Bryan A. Irving Ph.D. . Vice President, Cancer Immunology @CytomX Therapeutics, Inc.. Presenter Disclosure Information. The following relationships exist related to this presentation:. Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Practitioner. Abramson Cancer Center. University of Pennsylvania Health System. Disclosures of Conflicts of Interest. Ms. Eaby-Sandy, MSN, CRNP, OCN. ®. The Coming Paradigm Shift. Faculty. Suresh S. Ramalingam, MD. Professor of Hematology/Oncology . Director, Lung . Cancer Program . Winship Cancer Institute. Emory University. Atlanta, . Georgia. Program Goals. This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. A. HRICHI, S. KOUKI, M. LANDOULSI ,R. AOUINI, I. GANZOUI, S.BOUGUERRA, Y. AROUS, H. BOUJEMAA, N. BEN ABDALLAH. Radiology service, Main Military hospital of Instruction of Tunis, Tunisia. CH7. Inroduction. Consequences of the Lack of Patients of color & Structural barriers to Quality. Christopher S. Lathan, M.D., M.S., M.P.H. Assistant Professor of Medicine. Faculty Director of Cancer Care Equity, Dana-Farber Cancer Institute. EGF. Epidermal Growth Factor (EGF). Binds to . Epidermal Growth Factor . Receptor (EGFR). Results in . Cell Growth. Cell Proliferation. Cell Differentiation. Controls through the EGFR signaling pathway. Cécile Jovelet. Postdocoral. . fellow. Translational. . research. . lab. Gustave Roussy Institute, France. Introduction . 12/04/2017. 2. Lung cancer: . third most frequent cancer. Non-Small Cell Lung Cancer (NSCLC): 80% cases of lung cancer. Oropharyngeal cancers constitute less than %10 of allOropharyngeal cancers constitute less than %10 of allA vast majority (70%) of patients withoropharyngeal cancers are male. The main etiological fa Repiratory. block. SECOND . PRACTICAL. Respiratory Block. Pathology Dept. KSU. . TUBERCULOSIS. Epithelioid and giant cell Granuloma, . Ghon’s. . complex or caseation is present. Complications of TB are: . toxicity. ESDO Learning Bytes 2021. Dr Violaine RANDRIAN. Department of Gastroenterology, Poitiers University Hospital, France. DISCLOSURES. AMGEN. MERCK. PHARMAFIELD. BAYER. Anti-EGFR in Gastroenterology.
Download Document
Here is the link to download the presentation.
"EGFR Mutation in Lung Adenocarcinoma (ADC)"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents